Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.BackgroundHereditary tyrosinemia type 1 (HT1), which is associated with severe liver and kidney damage, is caused by deficiency of fumarylacetoacetate hydrolase (FAH), the last enzyme of the tyrosine breakdown cascade. HT1-associated liver and kidney failure can be prevented by blocking an enzyme upstream of FAH in the tyrosine breakdown pathway with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC). FAH knockout mice develop the HT1 phenotype when NTBC treatment is discontinued.MethodsThe occurrence of cell death was investigated in kidneys of Fah−/− mice on and off NTBC either unchallenged or injected with 800 mg...
Hereditary tyrosinemia type 1, due to a deficiency of fumarylacetoacetase (FAH), is characterized by...
Cisplatin, a standard chemotherapeutic agent for many tumors, has an unfortunately common toxicity w...
Reprogramming of cellular metabolism by oncogenic mutations probably creates specific vulnerabilitie...
AbstractHereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the ty...
AbstractHereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the ty...
Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal fa...
Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Recent studies sugge...
Mutations in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma1. Loss...
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal fai...
Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the ...
Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the ...
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal fai...
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal fai...
Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the ...
Hereditary tyrosinemia type I (HT1) is caused by deficiency in fumarylacetoacetate hydrolase (FAH), ...
Hereditary tyrosinemia type 1, due to a deficiency of fumarylacetoacetase (FAH), is characterized by...
Cisplatin, a standard chemotherapeutic agent for many tumors, has an unfortunately common toxicity w...
Reprogramming of cellular metabolism by oncogenic mutations probably creates specific vulnerabilitie...
AbstractHereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the ty...
AbstractHereditary tyrosinemia type 1 (HT1) is the most severe inherited metabolic disease of the ty...
Involvement of Fas-dependent apoptosis in renal tubular epithelial cell deletion in chronic renal fa...
Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. Recent studies sugge...
Mutations in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma1. Loss...
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal fai...
Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the ...
Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the ...
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal fai...
Chronic kidney disease (CKD) is characterized by renal fibrosis that can lead to end-stage renal fai...
Fumarate hydratase (FH) is an enzyme of the tricarboxylic acid cycle (TCA cycle) that catalyses the ...
Hereditary tyrosinemia type I (HT1) is caused by deficiency in fumarylacetoacetate hydrolase (FAH), ...
Hereditary tyrosinemia type 1, due to a deficiency of fumarylacetoacetase (FAH), is characterized by...
Cisplatin, a standard chemotherapeutic agent for many tumors, has an unfortunately common toxicity w...
Reprogramming of cellular metabolism by oncogenic mutations probably creates specific vulnerabilitie...